Orthopedic Biomaterial Market Research- Asia Pacific Forecast Till 2027

Asia Pacific Orthopedic Biomaterial Market Information, By Type Of Material (Metal, Non-Metal), By Application (Joint Replacement, Fracture Fixation Devices, Tissue Fixation, Spine Implants Viscosupplementation, And Others), And By End Users (Hospital, Clinics) - Forecast Till 2027

ID: MRFR/MED/0200-HCR | February 2021 | Region: Asia-Pacific | 50 pages

Asia Pacific Orthopedic Biomaterial Market Scenario

Orthopedic biomaterials are organic or synthetic materials used for the treatment of internal fractures. During the last decade different new techniques and materials are introduced for orthopedic implants and surgeries and biomaterials have found a vital role in it. These biomaterials are used in manufacturing of different implants since they do not evoke any immunological reactions with the body, which makes it a first choice for manufacturing of implants. Increasing demand for the orthopedic biomaterial because of its application in knee and hip replacement surgeries, and increasing incident of medical emergencies drive the Asia Pacific orthopedic biomaterial market. Introduction of novel implants of titanium has increased the success rate of implant surgeries and also contributed to the growth of the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries, increasing aging population, and growing governmental support also drive the Asia Pacific market. However, increasing failure in joints implants, stringent regulatory laws, and high cost of treatment may hinder the growth of Asia Pacific orthopedic biomaterial market during the review period.


The Asia Pacific orthopedic biomaterial market is expected to grow at a CAGR of 12.6% during the forecasted period 2017-2023.


Figure 1- Asia Pacific orthopedic biomaterial market, by application Asia Pacific Orthopedic Biometrial Market

  Sources: Annual reports, Press release, White paper, Company Presentation


Key Players

Some of the major players in Asia Pacific orthopedic biomaterial market: Kyocera Corporation (Japan), Materion Corporation (US), S&V Technologies (Germany), Rayner (UK), InVision Biomedical (US), Covestro (Germany), Invibio Ltd. (U.K.), Royal DSM (Netherlands), BASF SE (Germany), Corbion N.V. (Netherlands), CeramTec (Germany), Tianjin Walkman Biomaterial Co. (China), Kanghui Holdings (China), Johnson & Johnson Services, Inc. (US), Cam Bioceramics B.V. (Netherland), and Xian Airfoil Technology Co (China).

Segmentation

The orthopedic biomaterials market is segmented on the basis of types of material, applications, and end users. On the basis of types of material, the market is segmented into metals and non-metals.  The metals are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric, natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester, and other. The natural biomaterials are sub-segmented into collagen, chitin & chitosan, and other


On the basis of applications, the Asia Pacific orthopedic biomaterial market is segmented into joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and other. Joint replacement is sub-segmented into hip replacement, knee replacement, shoulder and elbow replacement, and other. Tissue fixation is sub-segmented into interference screws, suture anchors, and others. Spine implants are further sub-segmented into spine fusion and other. The fracture fixation devices are sub segmented into screws, plates for bones, rods, and other.


On the basis of end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.


Market Assessment Asia Pacific Orthopedic Biometrial Market-


Sources: Annual reports, World Health Organization (WHO), White paper, Company Presentation, International Osteoporosis Foundation


Regional Analysis

China dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the Asia Pacific orthopedic biomaterial market in this region. 


Intended Audience



  • Product manufacturers

  • Biomaterial manufacturer

  • Research and development (R&D) companies

  • Hospitals and laboratories

  • Medical research laboratories

  • Academic medical institutes and universities



Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :


The Asia Pacific Orthopedic Biomaterial Market CAGR would be 12.6% during the forecast period.

End users in the Asia Pacific Orthopedic Biomaterial Market are hospitals, clinics, and others.

China would dominate the Asia Pacific Orthopedic Biomaterial Market.

The applications of the Asia Pacific Orthopedic Biomaterial Market are viscosupplementation, fracture fixation devices, joint replacement, spine implants, tissue fixation, and other

Players involved are Materion Corporation (US), Kyocera Corporation (Japan), InVision Biomedical (US), S&V Technologies (Germany), Rayner (UK), Invibio Ltd. (U.K.), Royal DSM (Netherlands), Covestro (Germany), Corbion N.V. (Netherlands), BASF SE (Germany), Tianjin Walkman Biomaterial Co. (China), CeramTec (Germany), Cam Bioceramics B.V. (Netherland), Johnson & Johnson Services, Inc. (US), Kanghui Holdings (China), and Xian Airfoil Technology Co (China).

Table of Contents
1 Report Prologue

2 Market Introduction

2.1 Introduction

2.2 Scope of Study

2.3 Research Objective

2.4 Assumptions & Limitations

2.4.1 Assumptions

2.4.2 Limitations

3 Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

4 Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

5 Market Factor Analysis

5.1 Porter’s Five Forces Model

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Supply Chain Analysis

6 Asia Pacific Orthopedic Biomaterial Market, by Type of Material

6.1 Metal

6.1.1 Stainless Steel

6.1.2 Titanium Alloy

6.1.3 Cobalt Alloy

6.1.4 Others

6.2 Non- Metal

6.2.1 Ceramic

6.2.1.1 Alumina

6.2.1.2 Calcium Phosphate

6.2.1.3 Zirconium Dioxide

6.2.1.4 Carbon

6.2.1.5 Other

6.2.2 Polymeric

6.2.2.1 Polymethylmethacrylate (Pmma)

6.2.2.2 Polyethylene

6.2.2.3 Silicone

6.2.2.4 Polyester

6.2.2.5 Other

6.2.3 Natural Biomaterials

6.2.3.1 Collagen

6.2.3.2 Chitin & Chitosan

6.2.3.3 Other

6.3 Others.

7. Asia Pacific Orthopedic Biomaterial Market, by Application

7.1 Joint Replacement

7.1.1 Hip Replacement

7.1.2 Knee Replacement

7.1.3 Shoulder and Elbow Replacement

7.1.4 Other

7.2 Fracture Fixation Devices

7.2.1 Screws

7.2.2 Plates for Bones

7.2.3 Rods

7.2.4 Other

7.3 Tissue Fixation

7.3.1 Interference Screws

7.3.2 Suture Anchors

7.3.3 Others

7.4 Spine Implants

7.5 Viscosupplementation

7.6 Other

8 Asia Pacific Orthopedic Biomaterial Market, by Regions

8.1 Introduction

8.1.1 Japan

8.1.2 China

8.1.3 India

8.1.4 Australia

8.1.5 Republic of Korea

8.1.6 Rest of Asia-Pacific

9. Competitive Landscape

9.1 Major Strategies Adopted By Market Players

9.1.1 Strategic Partnership

9.1.2 Merger & Acquisition

10 Company Profile

10.1 Kyocera Corporation

10.1.1 Overview

10.1.2 Product Overview

10.1.3 Financials

10.1.4 Key Developments

10.2 Materion Corporation

10.2.1 Overview

10.2.2 Product Overview

10.2.3 Financials

10.2.4 Key Developments

10.3 Kanghui Holdings

10.3.1 Overview

10.3.2 Product Overview

10.3.3 Financials

10.3.4 Key Development

10.4 Royal Dsm

10.4.1 Overview

10.4.2 Product Overview

10.4.3 Financials

10.4.4 Key Developments

10.5 Ceramtec

10.5.1 Overview

10.5.2 Product Overview

10.5.3 Financials

10.5.4 Key Developments

10.6 Johnson & Johnson

10.6.1 Overview

10.6.2 Product Overview

10.6.3 Financials

10.6.4 Key Developments

10.7 Tianjin Walkman Biomaterial Co.

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.8 Cam Bioceramics B.V.

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.9 Covestro

10.9.1 Overview

10.9.2 Product Overview

10.9.3 Financials

10.9.4 Key Developments

10.10 Others

11 Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Prediction of Orthopedic Biomaterials Industry

12 Appendix